Cargando…
Influencing the decline of lung function in COPD: use of pharmacotherapy
Chronic obstructive pulmonary disease (COPD) is a common and deadly disease. One of the hallmarks of COPD is an accelerated decline in lung function, as measured by spirometry. Inflammation, oxidative stress and other pathways are hypothesized to be important in this deterioration. Because progressi...
Autores principales: | Gladysheva, Ekaterina S, Malhotra, Atul, Owens, Robert L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898088/ https://www.ncbi.nlm.nih.gov/pubmed/20631815 |
Ejemplares similares
-
Lung function decline in COPD
por: Tantucci, Claudio, et al.
Publicado: (2012) -
Pharmacotherapies for COPD
por: Ejiofor, Stan, et al.
Publicado: (2013) -
Positioning new pharmacotherapies for COPD
por: Barjaktarevic, Igor Z, et al.
Publicado: (2015) -
Genetic predisposition to accelerated decline of lung function in COPD
por: Molfino, Néstor A
Publicado: (2007) -
Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities
por: Matera, Maria Gabriella, et al.
Publicado: (2023)